Capstone Investment Advisors
IDYA icon

Capstone Investment Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Capstone Investment Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,050
Closed -$219K – 1815
2025
Q3 		$219K Buy
+8,050
New +$195K ﹤0.01% 1784
2024
Q2 		– Sell
-59,180
Closed -$2.6M – 2258
2024
Q1 		$2.6M Buy
59,180
+3,941
+7% +$169K 0.01% 673
2023
Q4 		$1.97M Buy
+55,239
New +$1.65M 0.01% 806

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Capstone Investment Advisors's IDYA Position: Q4 2025 in Review

Capstone Investment Advisors sold out of IDEAYA Biosciences (IDYA) in Q4 2025, closing a stake of 8,050 shares — an estimated $219K sold.

Capstone Investment Advisors first reported a position in IDYA in Q4 2023 and held it in 3 quarters. The position peaked at $2.6M in Q1 2024. 246 funds tracked by Wall St. Rank hold IDYA as of Q4 2025.

  • Capstone Investment Advisors reported no remaining IDEAYA Biosciences position as of Q4 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 8,050 IDEAYA Biosciences shares in Q4 2025, an estimated $219K.
  • Capstone Investment Advisors first reported a position in IDEAYA Biosciences in Q4 2023 and held it in 3 quarters.
  • Capstone Investment Advisors's IDEAYA Biosciences position peaked at $2.6M in Q1 2024.
  • 246 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q4 2025.

Based on Capstone Investment Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.